NCT04701710 Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc) (Q105047754)
Jump to navigation
Jump to search
interventional clinical trial NCT04701710 in Argentina treating COVID-19 with ivermectin and Iota-carrageenan
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NCT04701710 Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc) |
interventional clinical trial NCT04701710 in Argentina treating COVID-19 with ivermectin and Iota-carrageenan |
Statements
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc) (English)
1 reference
23 January 2021
300
0 references